Transforming science into patient value
Chiesi (chiesi.com) earns a Brand Analyzer score of 86 out of 100, placing it in the Strong Brand tier among Healthcare brands. Among 4829 Healthcare brands analyzed, Chiesi ranks in the 93rd percentile (category average 74, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 100/100, Digital Presence 100/100, Visual Identity 90/100, Messaging Clarity 95/100, Trust Foundation 84/100, AI Discoverability 82/100, Brand Authority 59/100.
Chiesi is an Italian biopharmaceutical group founded in 1935 and headquartered in Parma. It is research-oriented, developing and commercializing therapeutic solutions in respiratory health, rare diseases, and specialty care. The company emphasizes translating scientific research into patient benefits while maintaining sustainability and transparency in its operations. Chiesi operates globally, serving patients, healthcare professionals, and other stakeholders across its focus therapeutic areas.
| Brand Name | Chiesi |
|---|---|
| Domain | chiesi.com |
| Industry | Healthcare |
| Founded | 1935 |
| Headquarters | Parma |
| Main Competitors | GSK (83/100), AstraZeneca (82/100), Boehringer Ingelheim (76/100), Novartis (73/100), Sanofi (82/100), Teva Pharmaceutical Industries (86/100), Vertex Pharmaceuticals (88/100), Alexion Pharmaceuticals (87/100) |
Moz Domain Authority 46/100 vs category average 38 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #204,151 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Chiesi has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Siamo un gruppo biofarmaceutico orientato alla ricerca che sviluppa e commercializza soluzioni terapeutiche innovative per la salute respiratoria, le malattie rare e le cure specia…" (Meta description: 25 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is IT-only, limiting citation in English-language AI answers.
Detected tech stack: Apache.
Social footprint: verified profiles on LinkedIn, YouTube, X (Twitter), Instagram, GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Chiesi scores 60/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Chiesi has a moderate AI-visibility profile at 60/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (70/100) and its weakest is trust (46/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #204,151 (Tranco). The main gaps holding it back: no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Chiesi from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Chiesi?", Claude could identify the brand as of August 2026. Chiesi is an Italian pharmaceutical company based in Parma, focused on research and development in areas like respiratory disease, rare diseases, neonatology, and special care. It operates globally and has become a certified B Corp, emphasizing sustainability alongside its drug d Best known for Respiratory disease treatments, especially inhalers for asthma and COPD.
When asked "Best brands similar to Chiesi?", Claude would recommend Chiesi as of August 2026. It's a well-established, respected pharmaceutical company with a strong reputation in respiratory and rare disease treatment, making it relevant to mention in healthcare-related discussions.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Chiesi's main competitors include GSK (83/100), AstraZeneca (82/100), Boehringer Ingelheim (76/100), Novartis (73/100), Sanofi (82/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Chiesi and Vertex Pharmaceuticals are competitors in Healthcare. Brand Analyzer scores Chiesi at 86/100 and Vertex Pharmaceuticals at 88/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Chiesi include GSK (83/100), AstraZeneca (82/100), Boehringer Ingelheim (76/100), Novartis (73/100), Sanofi (82/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Chiesi is an Italian biopharmaceutical company headquartered in Parma, founded in 1935. It is a research-oriented group that develops and commercializes innovative therapeutic solutions.
Sources: Chiesi official site
Chiesi has moderate AI-search visibility, scoring 60/100 on Brand Analyzer's AI visibility composite (visibility 70, trust 46, recommendation 57). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Chiesi official site
Chiesi was founded in 1935. Chiesi operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Chiesi is headquartered in Parma. Chiesi operates in the Healthcare category.
Sources: Wikidata
Chiesi develops and commercializes therapeutic solutions focused on respiratory health, rare diseases, and specialty care, translating scientific research into treatments for patients worldwide.
Sources: Chiesi official site
Chiesi offers therapeutic solutions in three main areas: respiratory health, rare diseases, and specialty care. These are developed through research and commercialized for patients and healthcare professionals globally.
Sources: Chiesi official site
Chiesi scores 57/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Chiesi official site
Chiesi can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Chiesi official site
Chiesi is known for its work in respiratory health, rare diseases, and specialty care as a research-driven biopharmaceutical group with a stated commitment to sustainability and transparency.
Sources: Chiesi official site
Chiesi's offerings are used by patients, healthcare professionals, and other stakeholders involved in respiratory health, rare disease treatment, and specialty care worldwide.
Sources: Chiesi official site
Ranked closest to Chiesi: Chan Zuckerberg Initiative (86/100), Centrepoint (86/100), Deepak Chopra (86/100), Clarke (86/100).
A step up - brands to learn from: theSkimm (91/100), Replika (91/100).
Category leader: Elsevier (96/100).